Herantis Pharma publishes an introductory video on its drug candidate CDNF for the treatment of Parkinson's disease
Herantis Pharma publishes an introductory video on its drug candidate CDNF for the treatment of Parkinson's disease Herantis Pharma PlcPress release 29 March 2018 at 9:00 am Herantis Pharma Plc ("Herantis") has published an introductory video explaining how its innovative drug candidate CDNF works. The video is available online on Herantis' website at http://herantis.com/media/videos/. The development of CDNF aims at a breakthrough in the treatment of Parkinson's disease. "As part of our EU funded collaboration with the European Parkinson's disease association EPDA we want to